Levonorgestrel NDC 70700-164

NDC codes

FDA NDC Directory

Product NDC (as listed)70700-164Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70700-0164Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70700-164-06	70700016406	1 BLISTER PACK in 1 CARTON (70700-164-06) / 1 TABLET in 1 BLISTER PACKMarketed from Mar 13, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Levonorgestrel
Generic name (nonproprietary): levonorgestrel
Active ingredients: Levonorgestrel — 1.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Xiromed LLC
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205329
Marketing start: Mar 13, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Inhibit Ovum Fertilization (Physiologic effect)Progesterone Congeners (Chemical structure)Progesterone Congeners (Chemical structure)
Identifiers: Product ID 70700-164_6ccbcf9e-fe8a-a97f-06f9-a4e4726d919cSPL ID 6ccbcf9e-fe8a-a97f-06f9-a4e4726d919cSPL set ID 626a2333-ff56-ef28-a287-b33bacc0302aRxCUI 483325UNII 5W7SIA7YZWUPC 0370700164068
Pharmacologic class: Progestin; Progestin-containing Intrauterine System

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470700016406 followed by a unit qualifier and the quantity

Package 70700-0164-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 205329

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205329
Product	Strength	Form · route	Labeler	Product NDC
Morning Afterlevonorgestrel	Levonorgestrel 1.5 mg/1.5mg	TabletOral	Rapha Pharmaceuticals, Inc.	69953-517
Morning Afterlevonorgestrel	Levonorgestrel 1.5 mg/1.5mg	TabletOral	Rapha Pharmaceuticals, Inc.	69953-516
PostDay One-Steplevonorgestrel	Levonorgestrel 1.5 mg/1.5mg	TabletOral	Rapha Pharmaceuticals, Inc.	69953-617
PostDay One-Steplevonorgestrel	Levonorgestrel 1.5 mg/1.5mg	TabletOral	Rapha Pharmaceuticals, Inc.	69953-618
PostDay One-Steplevonorgestrel	Levonorgestrel 1.5 mg/1.5mg	TabletOral	Rapha Pharmaceuticals, Inc.	69953-628